GE HealthCare and Mayo Clinic launch prostate cancer theranostics study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. USO
7. AMD
8. AMC
9. META
10. COHR

Go back to GE HealthCare and Mayo Clinic launch prostate cancer theranostics study
(NASDAQ: GEHC) Delayed: 64.81 +0.68 (1.06%)
Previous Close $64.13    52 Week High $ 
Open $64.24    52 Week Low $ 
Day High $65.10    P/E N/A 
Day Low $63.71    EPS $ 
Volume 3,471,000